JPMorgan raised the firm’s price target on Teradyne to $110 from $100 and keeps a Neutral rating on the shares as part of a Q1 preview for the hardware and networking group. The sector is heading into Q1 earnings with one of the more benign macro backdrops in recent quarters, the analyst tells investors in a research note.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
